Literature DB >> 22628250

Molecular imaging of adrenal neoplasms.

Clara C Chen1, Jorge A Carrasquillo.   

Abstract

The adrenal glands are complex structures from which a variety of benign and malignant tumors may arise and are a common site of metastatic disease. Several radiopharmaceuticals are used for imaging the adrenals, including I-123/I-131 metaiodobenzylguanidine (MIBG), norcholesterol derivatives, In-111 pentetreotide and Ga-68 somatostatin analogs, [F-18]fluorodeoxyglucose, [F-18]fluorodopa, [F-18]fluorodopamine, C-11 meta hydroxyephedrine, and C-11/F-18/I-123 Metomidate (MTO) or its analogs. In this review we focus on the role of these reagents in metastatic lesions, cortical neoplasms, pheochromocytoma/paraganglioma, and neuroblastoma (NB).
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22628250      PMCID: PMC9207744          DOI: 10.1002/jso.23162

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   2.885


  114 in total

1.  Characterization of the normal adrenal gland with 18F-FDG PET/CT.

Authors:  Baharak Bagheri; Alan H Maurer; Libby Cone; Mohan Doss; Lee Adler
Journal:  J Nucl Med       Date:  2004-08       Impact factor: 10.057

2.  [18F]FETO for adrenocortical PET imaging: a pilot study in healthy volunteers.

Authors:  Wolfgang Wadsak; Markus Mitterhauser; Gundula Rendl; Matthias Schuetz; Leonhard Key Mien; Dagmar E Ettlinger; Robert Dudczak; Kurt Kletter; Georgios Karanikas
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-03-28       Impact factor: 9.236

3.  ¹²³I-MIBG scintigraphy/SPECT versus ¹⁸F-FDG PET in paediatric neuroblastoma.

Authors:  Henriette Ingrid Melzer; Eva Coppenrath; Irene Schmid; Michael H Albert; Dietrich von Schweinitz; Coral Tudball; Peter Bartenstein; Thomas Pfluger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-05-27       Impact factor: 9.236

4.  The role of 6-[18F]fluorodopamine positron emission tomography in the localization of adrenal pheochromocytoma associated with von Hippel-Lindau syndrome.

Authors:  Priya Kaji; Jorge A Carrasquillo; W Marston Linehan; Clara C Chen; Graeme Eisenhofer; Peter A Pinto; Edwin W Lai; Karel Pacak
Journal:  Eur J Endocrinol       Date:  2007-04       Impact factor: 6.664

5.  Quantitative determination of sst2 gene expression in neuroblastoma tumor predicts patient outcome.

Authors:  C C Raggi; M Maggi; D Renzi; A Calabrò; M L Bagnoni; P Scaruffi; G P Tonini; M Pazzagli; B De Bernardi; G Bernini; M Serio; C Orlando
Journal:  J Clin Endocrinol Metab       Date:  2000-10       Impact factor: 5.958

Review 6.  6-L-18F-fluorodihydroxyphenylalanine PET in neuroendocrine tumors: basic aspects and emerging clinical applications.

Authors:  Pieter L Jager; Raman Chirakal; Christopher J Marriott; Adrienne H Brouwers; Klaas Pieter Koopmans; Karen Y Gulenchyn
Journal:  J Nucl Med       Date:  2008-03-14       Impact factor: 10.057

7.  The utility of metaiodobenzylguanidine single photon emission computed tomography/computed tomography (MIBG SPECT/CT) for the diagnosis of pheochromocytoma.

Authors:  Goswin Y Meyer-Rochow; Geoff P Schembri; Diana E Benn; Mark S Sywak; Leigh W Delbridge; Bruce G Robinson; Paul J Roach; Stan B Sidhu
Journal:  Ann Surg Oncol       Date:  2009-12-01       Impact factor: 5.344

8.  PET hydroxyephedrine imaging of neuroblastoma.

Authors:  B L Shulkin; D M Wieland; M E Baro; D R Ungar; D S Mitchell; M G Dole; J B Rawwas; V P Castle; J C Sisson; R J Hutchinson
Journal:  J Nucl Med       Date:  1996-01       Impact factor: 10.057

9.  Imaging of adrenal incidentalomas with PET using (11)C-metomidate and (18)F-FDG.

Authors:  Heikki Minn; Anna Salonen; Johan Friberg; Anne Roivainen; Tapio Viljanen; Jaakko Långsjö; Jorma Salmi; Matti Välimäki; Kjell Någren; Pirjo Nuutila
Journal:  J Nucl Med       Date:  2004-06       Impact factor: 10.057

10.  The role of 18F-FDOPA and 18F-FDG-PET in the management of malignant and multifocal phaeochromocytomas.

Authors:  D Taïeb; L Tessonnier; F Sebag; P Niccoli-Sire; I Morange; C Colavolpe; C De Micco; A Barlier; F F Palazzo; J F Henry; O Mundler
Journal:  Clin Endocrinol (Oxf)       Date:  2008-04-03       Impact factor: 3.478

View more
  4 in total

Review 1.  Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatment.

Authors:  Victoria L Martucci; Karel Pacak
Journal:  Curr Probl Cancer       Date:  2014-01-15       Impact factor: 3.187

Review 2.  Metabolic and anatomic characteristics of benign and malignant adrenal masses on positron emission tomography/computed tomography: a review of literature.

Authors:  Asha Kandathil; Ka Kit Wong; Daniel J Wale; Maria Chiara Zatelli; Anna Margherita Maffione; Milton D Gross; Domenico Rubello
Journal:  Endocrine       Date:  2014-10-02       Impact factor: 3.633

3.  Role of 18F-FDG PET/CT in the differential diagnosis of primary benign and malignant unilateral adrenal tumors.

Authors:  Guangyu Ma; Xiaojun Zhang; Minshu Wang; Xiaodan Xu; Baixuan Xu; Zhiwei Guan
Journal:  Quant Imaging Med Surg       Date:  2021-05

Review 4.  Progress in the diagnosis and treatment of paraganglioma.

Authors:  Ben Wang; Jian Qiu
Journal:  Transl Cancer Res       Date:  2019-11       Impact factor: 1.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.